Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Eli Lilly Invests $1.2 Billion to Boost Oral Drug Production in Puerto Rico
Eli Lilly and Company has announced plans to invest more than $12 billion to expand and modernise its Lilly del Caribe manufacturing facility in Carolina, Puerto Rico The investment aims to strengthen the companys production
Merck Breaks Ground on $3 Billion Pharmaceutical Manufacturing Center in Virginia
Merck has started construction on a $3 billion Centre of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia The 400,000squarefoot facility is part of Mercks longterm plan to expand domestic
AstraZeneca Announces $4.5B Investment in Virginia Production Facility
AstraZeneca has announced a $45 billion investment in its new manufacturing facility at Rivanna Futures in Albemarle County, Virginia
AbbVie Invests $70 Million to Boost U.S. Biologics Manufacturing & R&D
AbbVie has started construction on a $70 million expansion at its AbbVie Bioresearch Center ABC in Worcester, Massachusetts The centre serves as a hub for biologics research, development, and manufacturing This expansion is part of AbbVies wider
Amgen Strengthens U.S. Footprint with $650M Investment
Amgen has announced a $650 million expansion of its US manufacturing network, aimed at increasing production capacity and integrating advanced technologies throughout its operations
GSK to Invest $30 Billion in R&D and Manufacturing in the United States
GSK plc has announced plans to invest $30 billion across the United States over the next five years in research and development and supply chain infrastructure The investment aims to strengthen GSKs innovation
Gilead Sciences Breaks Ground on $32 Billion U.S. Manufacturing Facility
Gilead Sciences has begun construction on a new Pharmaceutical Development and Manufacturing Technical Development Center NTDC at its headquarters in Foster City, California The fivestorey, 180,000 square foot facility
Johnson & Johnson Expands Operations with $2 Billion North Carolina Facility
Johnson Johnson has confirmed a $2 billion investment to expand its manufacturing presence in the United States This development is part of a wider strategy to increase advanced medicines production
AbbVie to Invest $195 Million in U.S. API Manufacturing Expansion
AbbVie has announced plans to invest $195 million in its North Chicago facility to increase active pharmaceutical ingredient API production in the United States The investment supports the companys strategy
AstraZeneca Announces $50 Billion Investment in US R&D and Manufacturing Facilities
AstraZeneca has announced a major investment of $50 billion in the United States The investment will strengthen the companys presence in both research and development RD and medicines manufacturing
